25 results
8-K
EX-99.2
KRYS
Krystal Biotech Inc
17 Nov 22
Regulation FD Disclosure
8:33am
during B-VEC clinical development program Vector data package includes B-VEC Phase 1/2 and Phase 3 studies, two clinical stage programs, and multiple
8-K
EX-1.1
53qtczpg
3 Dec 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-1.1
gxb56u eidftvvnx1dp
5 Feb 21
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-1.1
zewyg1k
21 May 20
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-1.1
ot8u 4jvnr0bm6e
27 Jun 19
Entry into a Material Definitive Agreement
4:28pm